EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Identification of New Pathogenic Variants of Hereditary Diffuse Gastric Cancer

Seung-Young Oh, Giyong Jang, Jaeryuk Kim, Kyoung-Yun Jeong, Hyun Myong Kim, Yoon Jin Kwak, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Sung-Yup Cho, Jong-Il Kim, Han-Kwang Yang

Cancer Research and Treatment · 2024

DOI: 10.4143/crt.2024.328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, 2024. Verfasst von Seung-Young Oh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Stomach Neoplasms, Genetic Predisposition to Disease, Pedigree, Germ-Line Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Seoul National University Hospital, National Research Foundation of Korea, Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Hereditary diffuse gastric cancer (HDGC) presents a significant genetic predisposition, notably linked to mutations in the CDH1 and CTNNA1. However, the genetic basis for over half of HDGC cases remains unidentified. The aim of this study is to identify novel pathogenic variants in HDGC and evaluate their protein expression.Materials and Methods Among 20 qualifying families, two were selected based on available pedigree and DNA. Whole genome sequencing (WGS) on DNA extracted from blood and whole exome sequencing on DNA from formalin-fixed paraffin-embedded tissues were performed to find potential pathogenic variants in HDGC. After selection of a candidate variant, functional validation, and enrichment analysis were performed.

Results

As a result of WGS, three candidate germline mutations (EPHA5, MCOA2, and RHOA) were identified in one family. After literature review and in-silico analyses, the RHOA mutation (R129W) was selected as a candidate. This mutation was found in two gastric cancer patients within the family. In functional validation, it showed RhoA overexpression and a higher GTP-bound state in the RhoaR129W mutant. Decreased phosphorylation at Ser127/397 suggested altered YAP1 regulation in the Rho-ROCK pathway. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses linked RhoaR129W overexpression to changed migration/adhesion in MKN1 cell line. However, this RHOA mutation (R129W) was not found in index patients in other families.

Conclusion

The RHOA mutation (R129W) emerges as a potential causative gene for HDGC, but only in one family, indicating a need for further studies to understand its role in HDGC pathogenesis fully.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsGenetic Predisposition to DiseasePedigreeGerm-Line MutationHumansMaleFemalerhoA GTP-Binding ProteinMiddle AgedAdultExome SequencingWhole Genome Sequencing

Stichwörter der Autor:innen

Familial gastric cancerGerm-line mutationHereditary diffuse gastric cancerPathogenic variantRHOA

Substanzen

rhoA GTP-Binding ProteinRHOA protein, human

Autor:innen und Institutionen

  • Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Korea.
  • Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Korea.
  • Ewha Biomedical Research Institute, Ewha Womans University Medical Center, Seoul, Korea.
  • Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea.

Förderung

  • Seoul National University Hospital
  • National Research Foundation of Korea
  • Ministry of Science and ICT
  • Ministry of Education

Zitieren

APA

Oh, S. Y., Jang, G., Kim, J., Jeong, K. Y., Kim, H. M., Kwak, Y. J., Kong, S. H., Park, D. J., Lee, H. J., Cho, S. Y., Kim, J. I., & Yang, H. K. (2024). Identification of New Pathogenic Variants of Hereditary Diffuse Gastric Cancer. Cancer Research and Treatment. https://doi.org/10.4143/crt.2024.328

Vancouver

Oh SY, Jang G, Kim J, Jeong KY, Kim HM, Kwak YJ, et al. Identification of New Pathogenic Variants of Hereditary Diffuse Gastric Cancer. Cancer Research and Treatment. 2024. doi:10.4143/crt.2024.328

BibTeX
@article{Oh2024,
  author = {Oh, Seung-Young and Jang, Giyong and Kim, Jaeryuk and Jeong, Kyoung-Yun and Kim, Hyun Myong and Kwak, Yoon Jin and Kong, Seong-Ho and Park, Do Joong and Lee, Hyuk-Joon and Cho, Sung-Yup and Kim, Jong-Il and Yang, Han-Kwang},
  title = {Identification of New Pathogenic Variants of Hereditary Diffuse Gastric Cancer},
  journal = {Cancer Research and Treatment},
  year = {2024},
  doi = {10.4143/crt.2024.328}
}
Kostenlos starten →